《大行報告》富瑞下調潤啤(00291.HK)目標價至62元 評級「買入」
富瑞發表報告指,華潤啤酒(00291.HK)去年銷售、經常性EBIT及經常性純利按年分別增長6.2%、21.5%及34.9%,意味去年下半年的銷售及經常性EBIT下跌2%及66.9%,經常性盈利則上升17.2%。
該行引述管理層稱今年會將焦點繼續放於中檔產品以上,目標是維持盈利有穩定的雙位數增長。
富瑞下調潤啤股份目標價,由68元降至62元,評級維持「買入」,並調低集團今明兩年經常性盈利預測8%至9%,以反映下調銷量增長預測,及原材料成本上升對毛利率造成壓力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.